Find clinical trials for Breast Cancer in Warszawa, Mazowieckie
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Warszawa, Mazowieckie, POL:
adjuvant systemic treatment instead of adjuvant chemotherapy followed by endocrine therapy in older patients with stage II-III ER+/HER2- early breast...
Phase 2
Warsaw, Poland and 72 other locations
look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...
Phase 3
Warszawa, Poland and 145 other locations
in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple negative breast...
Phase 1, Phase 2
Warszawa, Poland and 31 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Warszawa, Mazowieckie, Poland and 446 other locations
with inoperable or metastatic HR-positive, HER2- negative breast cancer who have been treated with one or two prior lines of...
Phase 3
Warszawa, Poland and 166 other locations
(BMs), with previously-treated advanced/metastatic HER2-positive breast cancer whose disease has progressed on prior anti-HER2-base...
Phase 3
Warszawa, Poland and 80 other locations
of fulvestrant or an aromatase inhibitor in women and men with breast cancer whose disease has advanced on one endocrine therapy in...
Phase 3
Otwock, Mazowieckie, Poland and 173 other locations
patients with locally advanced (inoperable) or metastatic HR+/HER2- breast cancer following recurrence or progression on or after A...
Phase 3
Warszawa, Poland and 214 other locations
multicentre Phase 2 study aimed to compare the efficacy and safety of oral AZD9833 versus intramuscular (IM) fulvestrant in women with advanced breast...
Phase 2
Warszawa, Poland and 90 other locations
growth factor receptor (HER)2-low, hormone receptor (HR) positive breast cancer patients whose disease has progressed on endocrine ...
Phase 3
Warszawa, Poland and 294 other locations
Clinical trials
Research sites
Resources
Legal